| Literature DB >> 32533515 |
Hisashi Takei1,2, Hirofumi Fukuda3, Gilbert Pan1, Hiroyuki Yamazaki3, Tadahiko Matsumoto3, Yasuhiro Kazuma3, Masanori Fujii1, Sohei Nakayama1, Ikei S Kobayashi1, Keisuke Shindo3, Riu Yamashita4, Kotaro Shirakawa3, Akifumi Takaori-Kondo3, Susumu S Kobayashi5,6,7.
Abstract
The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) protein family members have cytidine deaminase activity and can induce cytosine to uracil transition in nucleic acid. The main function of APOBEC3 (A3) proteins is to trigger an innate immune response to viral infections. Recent reports have shown that several APOBEC family proteins such as A3B can induce somatic mutations into genomic DNA and thus promote cancer development. However, the role of A3D on somatic mutations is unclear. Here, we identified the alternative splicing of A3D, and investigated each splice variant's subcellular localization and role in DNA mutagenesis. We identified four A3D variants, which all have one or two cytidine deaminase domains. The full-length form of A3D (variant 1) and truncated forms of A3D (variant 2, 6, 7) showed the ability to induce C/G to T/A transitions in foreign DNA and genomic DNA and retained antiretroviral activity. Furthermore, we demonstrated that A3D and A3B could induce deletions that are possibly repaired by microhomology-mediated end joining (MMEJ). Taken together, our experiments illustrated that alternative splicing generates functional diversity of A3D, and some variants can act as DNA mutators in genomic DNA.Entities:
Keywords: Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3D (APOBEC3D); Cytidine deaminase; Leukemia; Mutations; Resistance
Mesh:
Substances:
Year: 2020 PMID: 32533515 PMCID: PMC8713138 DOI: 10.1007/s12185-020-02904-y
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490